~13 spots leftby Nov 2025

Contact Lens Wear for Fuchs' Dystrophy

Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 1 & 2
Recruiting
Sponsor: Massachusetts Eye and Ear Infirmary
Disqualifiers: Pregnancy, others
No Placebo Group
Approved in 6 Jurisdictions

Trial Summary

What is the purpose of this trial?

The purpose of this study is to determine the difference in the cornea's response to contact lens placement between healthy and unhealthy eyes. The amount of corneal swelling (corneal thickness) between normal and FECD patients before and after a stress test will be measured and compared.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment of wearing contact lenses for Fuchs' Dystrophy?

Research suggests that contact lenses, including soft and rigid types, can help manage various corneal conditions by improving comfort and visual performance. For example, soft contact lenses have been beneficial in managing corneal erosions and promoting healing after surgery, while rigid lenses can help with irregular astigmatism, which may be relevant for Fuchs' Dystrophy.12345

Is wearing contact lenses generally safe for humans?

Contact lenses are generally safe for humans, but the risk of complications varies by type. Extended-wear soft lenses have a higher risk of complications like corneal ulcers compared to daily-wear lenses. Gas permeable lenses allow more oxygen to reach the eye, making them safer for prolonged use.678910

How does contact lens wear differ from other treatments for Fuchs' Dystrophy?

Contact lens wear for Fuchs' Dystrophy is unique because it can help manage symptoms by providing a protective barrier and promoting comfort, especially after surgical procedures. Unlike other treatments, contact lenses can also help with irregular astigmatism by providing a stable surface for the eye, which is not typically addressed by standard medical or surgical treatments.17111213

Research Team

Eligibility Criteria

This trial is for individuals with Fuchs endothelial corneal dystrophy (FECD) who are scheduled for a corneal transplant within the next 6 months. Participants should not have had previous eye surgery, contact lens intolerance, or other ocular diseases like glaucoma.

Inclusion Criteria

I am willing to undergo eye imaging tests.
I have been diagnosed with Fuchs' dystrophy.
I have never had eye diseases like surface issues or glaucoma.
See 3 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Stress Test

Participants wear an FDA-approved contact lens for three hours to induce corneal swelling

3 hours
1 visit (in-person)

Recovery Monitoring

Participants are monitored for corneal recovery after the stress test

3 hours
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the stress test

1 week

Treatment Details

Interventions

  • Wearing of contact lens (Procedure)
Trial OverviewThe study aims to measure how much the cornea swells in response to wearing a contact lens as a stress test. It compares this swelling between people with healthy eyes and those with FECD before and after the test.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Subjects with healthy eyesExperimental Treatment1 Intervention
Persons with healthy eyes will wear a contact lens in one eye for three hours.
Group II: Subjects with Fuch's Endothelial DystrophyActive Control1 Intervention
Persons with a diagnosis of Fuch's Endothelial Dystrophy will wear a contact lens in an affected eye for three hours.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts Eye and Ear Infirmary

Lead Sponsor

Trials
115
Recruited
15,000+

CarolAnn Williams

Massachusetts Eye and Ear Infirmary

Chief Executive Officer

MBA from Harvard Business School

Aalok Agarwala

Massachusetts Eye and Ear Infirmary

Chief Medical Officer since 2019

MD from University of California, Los Angeles

Findings from Research

Soft contact lenses can help manage conditions like recurrent corneal erosions and advanced bullous keratopathy, potentially improving patient comfort and aiding in tissue healing after surgery.
Rigid contact lenses are effective for patients with irregular astigmatism, providing a beneficial option for those with specific corneal dystrophies.
Contact Lenses in the Management of Corneal Dystrophies.Farooq, AV., Colby, K.[2020]
In a study of 10 eyes with advanced atopic keratoconjunctivitis, the use of rigid gas-permeable scleral contact lenses significantly improved visual acuity, with all patients gaining at least one line of vision and most gaining two or more lines after fitting.
The scleral contact lenses were well tolerated, with no reported complications or infections, indicating they are a safe option for managing ocular surface issues in these patients.
Role of rigid gas-permeable scleral contact lenses in the management of advanced atopic keratoconjunctivitis.Margolis, R., Thakrar, V., Perez, VL.[2007]
In a study involving 34 participants with corneal ectasia, scleral rigid gas permeable contact lenses (SL) were found to be significantly more comfortable than corneal rigid gas permeable contact lenses (CoL), with higher subjective comfort scores reported for SL.
Despite the comfort advantage of SL, there was no significant difference in visual performance or quality of life between SL and CoL, indicating that both lens types provide similar visual outcomes for successful CoL wearers.
Randomised controlled trial of corneal vs. scleral rigid gas permeable contact lenses for keratoconus and other ectatic corneal disorders.Levit, A., Benwell, M., Evans, BJW.[2021]

References

Contact Lenses in the Management of Corneal Dystrophies. [2020]
Role of rigid gas-permeable scleral contact lenses in the management of advanced atopic keratoconjunctivitis. [2007]
Randomised controlled trial of corneal vs. scleral rigid gas permeable contact lenses for keratoconus and other ectatic corneal disorders. [2021]
New contact lens challenges: the epithelial basement membrane dystrophy. [2004]
Success of Rigid Gas Permeable Contact Lens Fitting. [2017]
Nonulcerative complications of contact lens wear. Relative risks for different lens types. [2019]
Gas permeable lenses--a growing trend. [2004]
Corneal ulcer and adverse reaction rates in premarket contact lens studies. [2019]
A prospective multicenter clinical trial to assess safety and efficacy of Menicon SF-P RGP lenses for extended wear. [2017]
Use of contact lenses by firefighters: Part 2. Clinical evaluation. [2006]
11.United Statespubmed.ncbi.nlm.nih.gov
Nomogram for spherical RGP contact lens fitting in patients with pellucid marginal corneal degeneration (PMCD). [2015]
12.United Statespubmed.ncbi.nlm.nih.gov
The long-term use of the SoftPerm lens on pellucid marginal corneal degeneration. [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
Gas-permeable contact lenses can protect against ocular trauma: two cases. [2019]